In this latter study, loss of EZH2 reduced inflammatory responses to stimulus and so reduced disease severity, pointing the way to pharmacological inhibition of EZH2 as a therapeutic strategy in multiple sclerosis.15 Here, EZH2 is linked to multiple sclerosis.